Advanced MRI to tell returning brain tumors from radiation damage
Tests special MRI scans in adults with brain metastases after radiation treatment.
Key facts
- Who runs it
- Jonsson Comprehensive Cancer Center
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Registry title
- Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
- Status
- Recruiting
- People taking part
- 42 people, planned
- Started
- 28 Aug 2025
- Expected to end
- 30 Jul 2030
- Type of study
- Interventional, 2 groups
- Treatments tested
- Advanced Magnetic Resonance Imaging
- Biospecimen Collection
- Magnetic Resonance Imaging
- Record updated
- 15 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with cancer that has spread to the brain. They must be scheduled for brain surgery, a biopsy, or SRS (a focused radiation treatment).
- Age
- Older than 18 years
- Sex
- All sexes can join
- Disease stage
- Metastatic brain tumor (cancer that has spread to the brain from elsewhere).
- Earlier treatment
- People must be scheduled for surgery to remove the tumor or a tissue biopsy, with or without laser interstitial thermal therapy (LITT). Or they must be scheduled for SRS treatment.
Main reasons for not taking part
- Reasons they cannot have an MRI scan
- Severe kidney problems
- Signs that cancer has spread widely to the lining around the brain and spinal cord (disseminated leptomeningeal disease)
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age > 18 years old
- Diagnosed with metastatic brain tumor
- AIM 1: Scheduled for surgical resection or tissue biopsy +/- laser interstitial thermal therapy (LITT)
- AIM 2: Scheduled for SRS treatment
Who cannot take part
- Patients with contraindications to MRI, severe renal impairment
- Patients with evidence of disseminated leptomeningeal disease
This trial is currently available in United States.
- UCLA / Jonsson Comprehensive Cancer CenterLos Angeles, United StatesContact: Jingwen YaoTaking people
About the trial
What the trial wants to find out
This clinical trial studies whether advanced magnetic resonance imaging (MRI) techniques, including diffusion-relaxation correlation spectrum imaging (DR-CSI) and sodium imaging, can be used to identify the difference between brain tumors that come back after a period of improvement (recurrent) and treatment-related tissue damage (radiation necrosis [RN]). Radiation therapy is often used in the treatment of brain tumors. Radiation treatment response can be difficult to assess and is usually done using conventional MRI, which uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Current imaging techniques have a limited ability to identify the difference between recurrent brain tumor and RN due to their similar appearance on conventional MRI and overlapping clinical presentation. This makes it hard for doctors to plan the best way to treat these tumors. DR-CSI is a new MRI technique with the potential to detect microscopic tissue components with different characteristics. Sodium imaging is an MRI technique that estimates the total sodium concentration in the obtained images. It may be able to identify the small structures within the tissue of brain tumors. Advanced MRI techniques like DR-CSI and sodium imaging may be effective in identifying the difference between recurrent brain tumors and RN.
The 2 groups in the trial
- Aim 1 (advanced MRI)Treatment being tested
Patients undergo advanced DR-CSI and sodium MRI over 30 minutes prior to SOC surgical resection or biopsy. Patients also undergo clinical MRI and tissue sample collection on study.
Treatment: Advanced Magnetic Resonance Imaging, Biospecimen Collection, and Magnetic Resonance Imaging
- Aim 2 (advanced MRI)Treatment being tested
Patients undergo advanced DR-CSI and sodium MRI over 30 minutes before SRS and 2 weeks, 3 months, and 6 months post-SRS. Patients also undergo clinical MRI on study.
Treatment: Advanced Magnetic Resonance Imaging and Magnetic Resonance Imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Advanced Dual-Nuclei MRI for Differentiation of Recurrent Brain Metastases and Radiation Necrosis
- Plain-language title
- Advanced MRI to tell returning brain tumors from radiation damageGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 15 January 2026